Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Vomiting 1Ovarian Neoplasms 1Neoplasms 1Nausea 1Head and Neck Neoplasms 1Advanced Solid Tumor 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Injections, Intravenous × Clear all
NCT04718376 2024-03-07

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Relapsed Ovarian Cancer

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Terminated
56 enrolled
Gynecologic

Ovarian Neoplasms

NCT04902027 2024-03-07

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Recurrent/Metastatic Head and Neck Cancers

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Completed
45 enrolled
Head & Neck

Head and Neck Neoplasms

NCT04719065 2021-11-01

A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid Tumor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 1 Unknown
90 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT02563951 2016-01-08

Study of Granisetron Hydrochloride Nasal Spray (GNS) in Healthy Volunteers

Maxinase Life Sciences Ltd.

Phase 1 Completed
50 enrolled

Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡